Literature DB >> 23316797

The STAR of the DLC family.

Sally El-Sitt1, Mirvat El-Sibai.   

Abstract

RhoGTPases are defined as a family of 20 small G proteins playing important roles in almost every cellular process. RhoGTPases are guanine nucleotide-binding proteins existing in two forms: the active form which is GTP bound and the inactive one that being GDP bound. RhoGTPase-activating proteins known as RhoGAPs constitute one of the major classes of regulators of RhoGTPases. They act as negative regulators of the RhoGTPases by enhancing their slow intrinsic GTPase activity. STARD13, a GTPase activating protein (GAP) for RhoGTPases, has been described as a tumor suppressor in hepatocellular carcinoma. In the present review, we discuss the family of RhoGTPases, their regulation and their RhoGAPs, focusing mainly on STARD13.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23316797     DOI: 10.3109/10799893.2012.752002

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

Review 1.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

2.  StarD13 differentially regulates migration and invasion in prostate cancer cells.

Authors:  Leila Jaafar; Isabelle Fakhoury; Sahar Saab; Layal El-Hajjar; Wassim Abou-Kheir; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2021-01-09       Impact factor: 4.174

Review 3.  Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Authors:  Nicholas C Popescu; Steve Goodison
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

Review 4.  StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42.

Authors:  Sandra Abdellatef; Isabelle Fakhoury; Maria Al Haddad; Leila Jaafar; Hiba Maalouf; Samer Hanna; Bassem Khalil; Zeinab El Masri; Louis Hodgson; Mirvat El-Sibai
Journal:  Eur J Cell Biol       Date:  2021-12-21       Impact factor: 4.492

5.  DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.

Authors:  Dunrui Wang; Xiaolan Qian; Megha Rajaram; Marian E Durkin; Douglas R Lowy
Journal:  Oncotarget       Date:  2016-07-19

6.  Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.

Authors:  Maria Al Haddad; Rayane El-Rif; Samer Hanna; Leila Jaafar; Rayanne Dennaoui; Sandra Abdellatef; Veronika Miskolci; Dianne Cox; Louis Hodgson; Mirvat El-Sibai
Journal:  Cell Commun Signal       Date:  2020-09-08       Impact factor: 5.712

7.  RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells.

Authors:  Oula El Atat; Amira Fakih; Mirvat El-Sibai
Journal:  Cells       Date:  2019-02-18       Impact factor: 6.600

8.  Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.

Authors:  Yesim Gökmen-Polar; Jason D True; Edyta Vieth; Yuan Gu; Xiaoping Gu; Guihong D Qi; Amber L Mosley; Sunil S Badve
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.